Trials / Completed
CompletedNCT02535611
Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Mazandaran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The researchers aim to investigate the effect of memantine on stroke outcome in a randomized double-blind placebo-controlled clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Beside the usual treatment of ischemic stroke, this group will receive placebo for 4 weeks. |
| DRUG | Memantine | Beside the usual treatment for ischemic stroke this group will be treated by memantine. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-10-01
- Completion
- 2017-09-01
- First posted
- 2015-08-28
- Last updated
- 2020-10-06
- Results posted
- 2020-09-16
Source: ClinicalTrials.gov record NCT02535611. Inclusion in this directory is not an endorsement.